Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MULTIPLE MYELOMA, t(11;14) TYPE, SUSCEPTIBILITY TO
|
1 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.700 | 0 | |||||||
VON HIPPEL-LINDAU SYNDROME, MODIFIER OF
|
1 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.700 | 0 | |||||||
Benign Neoplasm
|
7 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Early-Stage Breast Carcinoma
|
7 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
COLORECTAL CANCER, SUSCEPTIBILITY TO
|
8 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.700 | 0 | |||||||
Primary amyloidosis
|
11 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.700 | 1.000 | 2 | 2017 | 2017 | ||||
Oral Mucositis
|
16 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Stomatitis
|
22 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Congenital chromosomal disease
|
47 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Malignant neoplasm of thyroid
|
103 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Head and Neck Carcinoma
|
118 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Malignant Head and Neck Neoplasm
|
118 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Thyroid Neoplasm
|
135 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Thyroid carcinoma
|
145 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Lip and Oral Cavity Carcinoma
|
172 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Malignant neoplasm of mouth
|
184 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Retinoblastoma
|
193 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Malignant tumor of cervix
|
245 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.040 | 1.000 | 4 | 2009 | 2018 | ||||
cervical cancer
|
268 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.040 | 1.000 | 4 | 2009 | 2018 | ||||
Colon Carcinoma
|
275 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Cervix carcinoma
|
283 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.040 | 1.000 | 4 | 2009 | 2018 | ||||
Squamous cell carcinoma of esophagus
|
329 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Squamous cell carcinoma of the head and neck
|
348 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Carcinogenesis
|
355 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Malignant tumor of colon
|
688 | 0.653 | 0.480 | 11 | 69648142 | splice region variant | G/A | snv | 0.45 | 0.39 | 0.010 | 1.000 | 1 | 2014 | 2014 |